中华临床医师杂志(电子版)
中華臨床醫師雜誌(電子版)
중화림상의사잡지(전자판)
CHINESE JOURNAL OF CLINICIANS(ELECTRONIC VERSION)
2015年
4期
531-533
,共3页
糖尿病肾病%他汀类药物
糖尿病腎病%他汀類藥物
당뇨병신병%타정류약물
Diabetic nephropathies%Statin
糖尿病肾病(DKD)患者心血管事件发生率显著增加。血脂异常与糖尿病和非糖尿病患者的肾功能损伤均有关。他汀类药物通过降脂和非依赖降脂途径保护 DKD 患者的肾功能,并显著减少DKD的心血管事件。因而DKD患者均应启动他汀治疗,其低密度脂蛋白胆固醇(LDL-C)的靶目标为<2.60 mmol/L,但血液透析的患者只在有明确需要治疗的心血管适应证时方启动他汀治疗。
糖尿病腎病(DKD)患者心血管事件髮生率顯著增加。血脂異常與糖尿病和非糖尿病患者的腎功能損傷均有關。他汀類藥物通過降脂和非依賴降脂途徑保護 DKD 患者的腎功能,併顯著減少DKD的心血管事件。因而DKD患者均應啟動他汀治療,其低密度脂蛋白膽固醇(LDL-C)的靶目標為<2.60 mmol/L,但血液透析的患者隻在有明確需要治療的心血管適應證時方啟動他汀治療。
당뇨병신병(DKD)환자심혈관사건발생솔현저증가。혈지이상여당뇨병화비당뇨병환자적신공능손상균유관。타정류약물통과강지화비의뢰강지도경보호 DKD 환자적신공능,병현저감소DKD적심혈관사건。인이DKD환자균응계동타정치료,기저밀도지단백담고순(LDL-C)적파목표위<2.60 mmol/L,단혈액투석적환자지재유명학수요치료적심혈관괄응증시방계동타정치료。
Diabetic kidney disease (DKD) is common among diabetic patients, and increases the cardiovascular outcomes significantly. Dislipidemia injuries kidney function in both diabetic patients and non-diabetic patients. It has been well demonstrated that statin significantly decreases cardiovascular outcomes and prolongs deterioration of kidney function among DKD patients. Therefore, statin was recommended for all DKD patients except those in consistent dialysis, whom statin was only used for cardiovascular reasons.